Sentence examples for to avoid reactivation from inspiring English sources

Increased age has been associated with a decrease in cell-mediated immunity, which is a crucial factor to avoid reactivation of the latent varicella zoster virus.

Retinal periphlebitis with strongly positive PPD test requires the use of systemic steroids and appropriate antituberculous therapy even in the absence of active systemic disease to avoid reactivation of the systemic illness.

EGF-induced ubiquitination thus is a secondary signal that redirects EGFR toward perinuclear areas with high PTP1B activity to inactivate signaling of the liganded receptor and further commit it for lysosomal degradation to avoid reactivation at the PM.

Expanded TB and HIV screening efforts, coupled with HIV risk reduction interventions and education about TB among these high-risk populations, are needed to avoid reactivation and spread of TB resulting from emergence of HIV in this Mexico/United States border region.

This observation is consistent with a recent study showing that flies are able to associate artificial activation of a random set of KCs instead of an odor stimulus with electric shock, and avoid reactivation of the same set of KCs in the absence of odors (Vasmer et al., 2014), a result that recapitulates a finding in the potentially analogous piriform cortex of rodents (Choi et al., 2011).

The UV treated petri plates were taken out at regular intervals (15-, 30-, 45-s, 1-, 5-, 15-, 30- and 60-min) and then incubated at 40°C for 72 h under dark conditions to avoid photo reactivation.

20 So, it might be the reason that IMRT didn't contribute to avoid HBV reactivation at all, but rather than a little risky numerically.

The case described here underscores the need for a careful and multidisciplinary evaluation of inmate patients for latent TB before administration of Peg-IFN and ribavirin therapy, thus avoiding reactivation.

Therefore, the mTOR and PI3K dual-specificity inhibitors might be sufficient to avoid PI3K pathway reactivation.

Recently, we have suggested that screening and constant monitoring of LTBI during TNF-α blocker therapy are determinants for continued treatment of PsA, in order to avoid risks of reactivation of tubercular disease.

The second phase started when an adjustment was made in the immunosuppression protocol, with a lower dosage being adopted to avoid adverse effects (neoplasias and reactivation).